| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/20/2011 | US20110015187 Substituted heteroarylamide diazepinopyrimidone derivatives |
| 01/20/2011 | US20110015186 Methods and compositions for protecting and treating neuroinjury |
| 01/20/2011 | US20110015185 Benzofuran Compounds |
| 01/20/2011 | US20110015184 Vinyl-phenyl derivatives for inflammation and immune-related uses |
| 01/20/2011 | US20110015183 Substituted pyrazole sigma receptor antagonists |
| 01/20/2011 | US20110015182 Novel carbamate amino acid and peptide prodrugs of opioids and uses thereof |
| 01/20/2011 | US20110015181 Alkylaminopyridine derivative |
| 01/20/2011 | US20110015180 Chemokine receptor antagonists |
| 01/20/2011 | US20110015179 Compositions for treating cognitive disorders |
| 01/20/2011 | US20110015178 Amido-Thiophene Compounds and Their Use |
| 01/20/2011 | US20110015177 Substituted arylamide oxazepinopyrimidone derivatives |
| 01/20/2011 | US20110015176 Substituted heteroarylamide oxazepinopyrimidone derivatives |
| 01/20/2011 | US20110015175 Bicyclic Compounds for the Reduction of Beta-Amyloid Production |
| 01/20/2011 | US20110015174 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 01/20/2011 | US20110015173 Pyrrolopyridine inhibitors of kinases |
| 01/20/2011 | US20110015172 Pyrrolopyrazine inhibitors of kinases |
| 01/20/2011 | US20110015171 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/20/2011 | US20110015170 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/20/2011 | US20110015169 Methods for in vitro maturation of ovarian follicles |
| 01/20/2011 | US20110015168 Methods for increasing levels of human fetal hemoglobin |
| 01/20/2011 | US20110015167 Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels |
| 01/20/2011 | US20110015166 Topically Active Steroids for Use in Interstitial Pulmonary Fibrosis |
| 01/20/2011 | US20110015165 Modified, hydroxy-substituted aromatic structures having cytoprotective activity |
| 01/20/2011 | US20110015164 Method of treating men with metabolic and anthropometric disorders |
| 01/20/2011 | US20110015163 Crystalline freebase forms of a biphenyl compound |
| 01/20/2011 | US20110015162 15,16-Methylene-17-hydroxy-19-nor-21-carboxylic acid-steroid Y-lactone derivative, use thereof and medicinal products containing the derivative |
| 01/20/2011 | US20110015161 Pharmaceutical containing a horomone combination having a contraceptive effecr and an insulin sensitizer |
| 01/20/2011 | US20110015160 Methods of treating neurological diseases using docosahexaenoic acid and arachidonic acid compositions |
| 01/20/2011 | US20110015159 Methods of inhibiting vascular permeability and apoptosis |
| 01/20/2011 | US20110015158 Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
| 01/20/2011 | US20110015157 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/20/2011 | US20110015156 Heterocyclic compounds for the treatment of neurological and psychological disorders |
| 01/20/2011 | US20110015155 Deuterated 2, 4-Pyrimidinediamine Compounds and Prodrugs Thereof and Their Uses |
| 01/20/2011 | US20110015154 Supporting acetylcholine function |
| 01/20/2011 | US20110015153 Fly control method |
| 01/20/2011 | US20110015152 Diarylmethyl and related compounds |
| 01/20/2011 | US20110015151 Combination of viscoelastics for use during surgery |
| 01/20/2011 | US20110015150 Methods of administering compositions including iron |
| 01/20/2011 | US20110015149 Compounds, compositions and methods for the treatment of viral infections and other medical disorders |
| 01/20/2011 | US20110015148 Antiviral nucleosides |
| 01/20/2011 | US20110015147 Anti-viral pyrimidine nucleoside analogues |
| 01/20/2011 | US20110015146 Nucleoside phosphoramidates |
| 01/20/2011 | US20110015145 Cladribine formulations for improved oral and transmucosal delivery |
| 01/20/2011 | US20110015144 Administration method proposing device |
| 01/20/2011 | US20110015143 Use Of One Or More Of Glycyrrhizic Acid For Reducing The Irritating Action Of Surfactants In Cosmetic Compositions |
| 01/20/2011 | US20110015142 Method for preparing gynostemma pentaphyllum extract with increasing damulin a and damulin b contents, and pharmaceutical compositions of the same for treating metabolic disease |
| 01/20/2011 | US20110015141 Method for treating cancers having high glucose requirements employing an sglt2 inhibitor and compositions thereof |
| 01/20/2011 | US20110015140 Anti-diabetes composition containing chicoric acid and/or one of the metabolites thereof |
| 01/20/2011 | US20110015137 Reca inhibitors and their uses as microbial inhibitors or potentiators of antibiotic activity |
| 01/20/2011 | US20110015136 humanized model of membrane attack complex (MAC) formation on murine retina and compositions, kits and methods for treatment of macular degeneration |
| 01/20/2011 | US20110015134 Method of treatment for early stage cancer |
| 01/20/2011 | US20110015129 New paediatric indications for direct thrombin inhibitors |
| 01/20/2011 | US20110015123 Modulation of GLUT4 Gene Promoter activity BY AHNAK |
| 01/20/2011 | US20110015120 Pharmaceutical and cosmetic compositions including lactoferrin, ciclopirox, etidronic acid |
| 01/20/2011 | US20110014641 Method for measuring aromatase activity |
| 01/20/2011 | US20110014308 Novel compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders. |
| 01/20/2011 | US20110014306 Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques |
| 01/20/2011 | US20110014304 Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders |
| 01/20/2011 | US20110014303 Method for the treatment of cancer |
| 01/20/2011 | US20110014299 Solid preparation comprising alogliptin and metformin hydrochloride |
| 01/20/2011 | US20110014295 Method of determining the weight of the coating to be applied to form a controlled release dosage form |
| 01/20/2011 | US20110014294 Stimulation of ocular retrobulbar blood flow using ocular irritants |
| 01/20/2011 | US20110014292 method of prophylaxis and agents for use therein |
| 01/20/2011 | US20110014291 Novel Polymorphs of Bosentan |
| 01/20/2011 | US20110014289 Reticulated Elastomeric Matrices, Their Manufacture and Use in Implantable Devices |
| 01/20/2011 | US20110014288 Microcapsules comprising a fat-soluble active substance |
| 01/20/2011 | US20110014287 Silk Fibroin Hydrogels and Uses Thereof |
| 01/20/2011 | US20110014286 Mixture for producing rapidly disintegrating tablets |
| 01/20/2011 | US20110014285 N-acetyl cysteine compositions and methods to improve the therapeutic efficacy of acetaminophen |
| 01/20/2011 | US20110014284 Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof |
| 01/20/2011 | US20110014283 Novel dosage form |
| 01/20/2011 | US20110014282 Pharmaceutical composition for poorly soluble drugs |
| 01/20/2011 | US20110014281 Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
| 01/20/2011 | US20110014280 Sequestering subunit and related compositions and methods |
| 01/20/2011 | US20110014277 Smoking Cessation With Body Weight Maintenance And Nutritional Supplement |
| 01/20/2011 | US20110014275 Compositions and methods for inhibiting or inducing adipogenesis |
| 01/20/2011 | US20110014273 Method of Treating BCC |
| 01/20/2011 | US20110014271 Substituted Aniline Derivatives |
| 01/20/2011 | US20110014269 Civamide patch for localized post-incisional neuropathic pain |
| 01/20/2011 | US20110014265 Implant Improving Local Bone Formation |
| 01/20/2011 | US20110014264 Medical Devices Having Nanostructured Regions For Controlled Tissue Biocompatibility And Drug Delivery |
| 01/20/2011 | US20110014259 Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis |
| 01/20/2011 | US20110014258 Gradient coating for biomedical applications |
| 01/20/2011 | US20110014250 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages |
| 01/20/2011 | US20110014246 Amorphous arformoterol l-(+)-tartrate |
| 01/20/2011 | US20110014245 Therapeutic method of administering pharmaceutical titanium dioxide composite and light irradiation |
| 01/20/2011 | US20110014243 Pharmaceutical compositions |
| 01/20/2011 | US20110014227 Pre-or post-exposure treatment for filovirus or arenavirus infection |
| 01/20/2011 | US20110014219 Norovirus and Sapovirus antigens |
| 01/20/2011 | US20110014214 Diagnostic and Therapeutic Utility of Tribbles-2 in Human Cancers |
| 01/20/2011 | US20110014212 Certain Chemical Entities, Compositions and Methods |
| 01/20/2011 | US20110014210 Chlamydia vaccine |
| 01/20/2011 | US20110014206 Screening at least one individual for a mutation in a gene coding for a Poly-Ig (Fc) receptor or a Poly-Ig-like (Fc) receptor capable of mediating inhibition of cancer cell growth by an immunoglobulin inhibitor |
| 01/20/2011 | US20110014205 Methods and compositions for treating chronic pelvic pain syndrome |
| 01/20/2011 | US20110014204 Cancer Chemoprevention Strategy Based on Loss of Imprinting of IGF2 |
| 01/20/2011 | US20110014202 Methods for Diagnosing and Treating Neuroendocrine Cancer |
| 01/20/2011 | US20110014197 Methods of treating pre-eclampsia or eclampsia |
| 01/20/2011 | US20110014196 Drug Transfer into Living Cells |
| 01/20/2011 | US20110014192 Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with metabolic modulators |
| 01/20/2011 | US20110014188 TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease |